Mirum Pharmaceuticals (NasdaqGM:MIRM) and GeneDx expanded their no cost genetic testing collaboration to cover multiple rare conditions. The program now includes testing for early onset cataracts and ...
Source LinkMirum Pharmaceuticals (NasdaqGM:MIRM) and GeneDx expanded their no cost genetic testing collaboration to cover multiple rare conditions. The program now includes testing for early onset cataracts and ...
Source Link
Comments